These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26599819)

  • 21. Triglyceride Paradox Is Related to Lipoprotein Size, Visceral Adiposity and Stearoyl-CoA Desaturase Activity in Black Versus White Women.
    Chung ST; Cravalho CKL; Meyers AG; Courville AB; Yang S; Matthan NR; Mabundo L; Sampson M; Ouwerkerk R; Gharib AM; Lichtenstein AH; Remaley AT; Sumner AE
    Circ Res; 2020 Jan; 126(1):94-108. PubMed ID: 31623522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. No effect of resveratrol on VLDL-TG kinetics and insulin sensitivity in obese men with nonalcoholic fatty liver disease.
    Poulsen MK; Nellemann B; Bibby BM; Stødkilde-Jørgensen H; Pedersen SB; Grønbaek H; Nielsen S
    Diabetes Obes Metab; 2018 Oct; 20(10):2504-2509. PubMed ID: 29885082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adiponectin is associated with favorable lipoprotein profile, independent of BMI and insulin resistance, in adolescents.
    Magge SN; Stettler N; Koren D; Levitt Katz LE; Gallagher PR; Mohler ER; Rader DJ
    J Clin Endocrinol Metab; 2011 May; 96(5):1549-54. PubMed ID: 21367935
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic Determinants of Circulating Lipoproteins in Nonalcoholic Fatty Liver Disease.
    Jiang ZG; Tapper EB; Kim M; Connelly MA; Krawczyk SA; Yee EU; Herman MA; Mukamal KJ; Lai M
    J Clin Gastroenterol; 2018; 52(5):444-451. PubMed ID: 28362682
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Laparoscopic sleeve gastrectomy alters
    Cabré N; Gil M; Amigó N; Luciano-Mateo F; Baiges-Gaya G; Fernández-Arroyo S; Rodríguez-Tomàs E; Hernández-Aguilera A; Castañé H; París M; Sabench F; Del Castillo D; Camps J; Joven J
    Sci Rep; 2021 Jan; 11(1):1343. PubMed ID: 33446705
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.
    Meis SB; Schuster D; Gaillard T; Osei K
    Ethn Dis; 2006; 16(4):830-6. PubMed ID: 17061734
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease.
    Fabbrini E; Mohammed BS; Magkos F; Korenblat KM; Patterson BW; Klein S
    Gastroenterology; 2008 Feb; 134(2):424-31. PubMed ID: 18242210
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thioesterase Superfamily Member 2 Promotes Hepatic VLDL Secretion by Channeling Fatty Acids Into Triglyceride Biosynthesis.
    Alves-Bezerra M; Li Y; Acuña M; Ivanova AA; Corey KE; Ortlund EA; Cohen DE
    Hepatology; 2019 Aug; 70(2):496-510. PubMed ID: 30516845
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-high-density lipoprotein cholesterol as a biomarker for nonalcoholic steatohepatitis.
    Corey KE; Lai M; Gelrud LG; Misdraji J; Barlow LL; Zheng H; Andersson KL; Thiim M; Pratt DS; Chung RT
    Clin Gastroenterol Hepatol; 2012 Jun; 10(6):651-6. PubMed ID: 22330232
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low- and high-density lipoprotein subclasses in subjects with nonalcoholic fatty liver disease.
    Sonmez A; Nikolic D; Dogru T; Ercin CN; Genc H; Cesur M; Tapan S; Karslioğlu Y; Montalto G; Banach M; Toth PP; Bagci S; Rizzo M
    J Clin Lipidol; 2015; 9(4):576-82. PubMed ID: 26228676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
    Portillo-Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2231-8. PubMed ID: 25885947
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethnic differences in lipoprotein subclasses in obese adolescents: importance of liver and intraabdominal fat accretion.
    D'Adamo E; Northrup V; Weiss R; Santoro N; Pierpont B; Savoye M; O'Malley G; Caprio S
    Am J Clin Nutr; 2010 Sep; 92(3):500-8. PubMed ID: 20573788
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discordant association of nonalcoholic fatty liver disease with lipoprotein(a) and markers of atherogenic dyslipidemia.
    Mehta A; Lee TB; Alebna P; Grandhi GR; Dixon DL; Salloum FN; Sanyal AJ; Siddiqui MS
    J Clin Lipidol; 2023; 17(6):828-833. PubMed ID: 37957050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IMPACT OF TYPE 2 DIABETES ON NONALCOHOLIC STEATOHEPATITIS AND ADVANCED FIBROSIS IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE.
    Bian H; Zhu X; Xia M; Yan H; Chang X; Hu X; Pan B; Guo W; Li X; Gao X
    Endocr Pract; 2020 Apr; 26(4):444-453. PubMed ID: 31968197
    [No Abstract]   [Full Text] [Related]  

  • 36. Impact of insulin resistance on lipoprotein subpopulation distribution in lean and morbidly obese nondiabetic women.
    MacLean PS; Vadlamudi S; MacDonald KG; Pories WJ; Houmard JA; Barakat HA
    Metabolism; 2000 Mar; 49(3):285-92. PubMed ID: 10726902
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HDL flux is higher in patients with nonalcoholic fatty liver disease.
    McCullough A; Previs SF; Dasarathy J; Lee K; Osme A; Kim C; Ilchenko S; Lorkowski SW; Smith JD; Dasarathy S; Kasumov T
    Am J Physiol Endocrinol Metab; 2019 Nov; 317(5):E852-E862. PubMed ID: 31503515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased atherogenic lipoprotein profile in children with non-alcoholic steatohepatitis.
    Castillo-Leon E; Connelly MA; Konomi JV; Caltharp S; Cleeton R; Vos MB
    Pediatr Obes; 2020 Sep; 15(9):e12648. PubMed ID: 32367624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ectodysplasin A Is Increased in Non-Alcoholic Fatty Liver Disease, But Is Not Associated With Type 2 Diabetes.
    Bayliss J; Ooi GJ; De Nardo W; Shah YJH; Montgomery MK; McLean C; Kemp W; Roberts SK; Brown WA; Burton PR; Watt MJ
    Front Endocrinol (Lausanne); 2021; 12():642432. PubMed ID: 33746906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical characteristics and risk factors of nonalcoholic fatty liver disease in children with obesity.
    Peng L; Wu S; Zhou N; Zhu S; Liu Q; Li X
    BMC Pediatr; 2021 Mar; 21(1):122. PubMed ID: 33711964
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.